Physiomics Plc engages in the provision of outsourced systems and computational biology services to pharmaceutical companies. Its services include target validation, mechanism of action studies, lead selection, clinical PK or PD, EasyAP or cardiac toxicity service, virtual tumor preclinical, and virtual tumor clinical. The company was founded by David A. Fell and Peter Hoskins in May 2001 and is headquartered in Oxford, the United Kingdom.